Table 2.
n | Coefficient | β | p Value | |
Age | 146 | 0.12 | 0.22 | <0.01 |
Female sex (reference male) | 146 | −0.19 | −0.08 | 0.34 |
Pubertal stage (reference late/complete) | 146 | |||
pre/early (1&2) | −0.15 | 0.01 | 0.68 | |
mid (3/4) | −0.12 | 0.61 | 0.67 | |
Ethnicity (reference white) | 146 | 0 | ||
Black | 0.42 | 0.17 | 0.07 | |
South Asian | 0.67 | 0.23 | 0.01 | |
Mixed other | 0.18 | 0.05 | 0.60 | |
Current smoker | 0.27 | 0.07 | 0.43 | |
Ever smoked | 0.15 | 0.06 | 0.47 | |
Height z | 146 | −0.13 | −0.11 | 0.18 |
zBMI | 146 | 0.44 | 0.20 | 0.01* |
Fat mass index | 144 | 0.05 | 0.18 | 0.03* |
Waist-z | 146 | 0.27 | 0.17 | 0.04* |
SAD | 132 | 0.06 | 0.18 | 0.04* |
Systolic z | 146 | 0.02 | 0.02 | 0.83 |
Diastolic z | 146 | 0.08 | 0.08 | 0.33 |
Cholesterol | 146 | 0.16 | 0.12 | 0.16 |
High cholesterol vs low | 146 | −0.35 | −0.11 | 0.20 |
HDL | 142 | 0.16 | 0.03 | 0.68 |
Low HDL vs high | 142 | - 0.63 | −0.17 | 0.04* |
Triglycerides | 145 | 0.24 | 0.13 | 0.13 |
Abnormal triglycerides vs normal | 145 | 0.52 | 0.17 | 0.04* |
ALT | 146 | 0.01 | 0.14 | 0.08 |
Fasting glucose | 146 | 0.04 | 0.02 | 0.86 |
HbA1c | 146 | 0.23 | 0.07 | 0.38 |
Fasting insulin | 146 | 0.01 | 0.06 | 0.50 |
Abnormal insulin vs normal | 146 | 0.17 | 0.50 | |
HOMA-IR | 146 | 0.01 | 0.01 | 0.76 |
Abnormal HOMA-IR vs normal | 146 | 0.03 | 0.01 | 0.91 |
*Statisically significant, p<0.05.
BMI, body mass index; BP, blood pressure; FMI, fat mass index; HbA1c, haemoglobin 1c; HOMA, homeostatic model assessment-insulin resistance; PWV, pulse wave velocity; SAD, anterior-posterior sagittal abdominal dimension; z, z-score.